Haisco Pharmaceutical Group (002653.SZ) has granted 5.8 million restricted shares.

19/09/2024

GMT Eight

Haisco Pharmaceutical Group (002653.SZ) announced that the Board of Directors believes that the conditions for granting the restricted stock incentive plan for 2024 have been met. They have agreed to designate September 19, 2024 as the grant date, and to grant 5.8 million shares of restricted stock to six incentive recipients who meet the granting conditions. The grant price for the restricted stock is 13.955 yuan per share.

CHINA HEALTH (00673) recommends appointing Beijing Xinghua as the auditor.

Anhui Wanbang Pharmaceutical Technology (301520.SZ) approximately 5.4068 million restricted shares will be listed for trading on September 25.

Contact: contact@gmteight.com

Haisco Pharmaceutical Group (002653.SZ) has granted 5.8 million restricted shares.

RECOMMEND

TEXWINCA HOLD(00321) will distribute a special interim dividend of 3 Hong Kong cents per share on January 8, 2025.

TEXWINCA HOLD(00321) will distribute a mid-term dividend of 1 HK cent per share on January 8, 2025.

TEXWINCA HOLDINGS (00321) announces its interim financial results, with the attributable profit to shareholders reaching approximately HK$101.5 million, representing a year-on-year increase of 132.4%.